Alaunos Therapeutics | ZIOP - Sales Revenues

Stock Price
3.15
Daily Change
0.02 0.64%
Monthly
6.78%
Yearly
96.88%
Q1 Forecast
2.64

Alaunos Therapeutics reported $2K in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Amgen USD 9.9B 340M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Biogen USD 2.28B 250M Dec/2025
Bioline Rx USD 427K 123K Sep/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Celltrion KRW 1.33T 300B Mar/2026
Corcept Therapeutics USD 202.12M 5.48M Dec/2025
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Curis USD 2.55M 460K Jun/2024
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 396K 203K Sep/2025
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Incyte USD 1.51B 140M Dec/2025
Intrexon USD 717K 511K Jun/2024
Ionis Pharmaceuticals USD 203M 46M Dec/2025
J&J USD 24.6B 610M Dec/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Karyopharm Therapeutics USD 30.54M 8.24M Dec/2024
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Medical Developments International AUD 9.53M 1.99M Jun/2025
Merck USD 16.4B 880M Dec/2025
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025
Novartis USD 13.91B 144M Sep/2025
Organigram Holdings CAD 80.06M 9.27M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Pharma Mar EUR 35.7M 20.69M Sep/2025
PTC Therapeutics USD 164.7M 46.3M Dec/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sangamo BioSciences USD 356K 125K Jun/2024
Sartorius EUR 927.6M 84.4M Dec/2025
Sino Biopharmaceutical CNY 17.57B 4.58B Jun/2025
TG Therapeutics USD 192.57M 30.87M Dec/2025
Tilray USD 217.51M 74.75M Dec/2025
Verastem USD 0 10M Sep/2024
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025